| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |